Arcus Biosciences (RCUS) PT Raised to $40 at Goldman Sachs

March 1, 2021 6:00 AM EST
Get Alerts RCUS Hot Sheet
Price: $24.89 +0.04%

Rating Summary:
    10 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 12 | Down: 7 | New: 31
Trade Now! 
Join SI Premium – FREE
Goldman Sachs raised its price target on Arcus Biosciences (NYSE: RCUS) to $40.00 (from $36.00) while maintaining a Neutral rating.

You May Also Be Interested In

Related Categories

Analyst PT Change